351.79美元1.52(0.43%)
2025/06/12更新
績效 / 1月2.4%
3月3.41%
1年6.57%
晨星評等 - 1.現金1.32%
- 2.股票30.15%
- 3.債券0.00%
- 4.其他68.53%
- 1.美國68.53%
- 2.歐元區9.27%
- 3.英國7.67%
- 4.歐洲不包含歐元區7.63%
- 5.日本3.10%
- 1.AstraZeneca PLC7.40%
- 2.Eli Lilly and Co6.99%
- 3.UnitedHealth Group Inc6.03%
- 4.Sanofi SA5.94%
- 5.Boston Scientific Corp4.66%
- 6.Regeneron Pharmaceuticals Inc4.10%
- 7.Vertex Pharmaceuticals Inc3.98%
- 8.Intuitive Surgical Inc3.92%
- 9.Neurocrine Biosciences Inc3.78%
- 10.Gilead Sciences Inc3.73%
- 1.現金1.32%
- 2.股票30.15%
- 3.債券0.00%
- 4.其他68.53%
- 1.美國68.53%
- 2.歐元區9.27%
- 3.英國7.67%
- 4.歐洲不包含歐元區7.63%
- 5.日本3.10%
- 1.AstraZeneca PLC7.40%
- 2.Eli Lilly and Co6.99%
- 3.UnitedHealth Group Inc6.03%
- 4.Sanofi SA5.94%
- 5.Boston Scientific Corp4.66%
- 6.Regeneron Pharmaceuticals Inc4.10%
- 7.Vertex Pharmaceuticals Inc3.98%
- 8.Intuitive Surgical Inc3.92%
- 9.Neurocrine Biosciences Inc3.78%
- 10.Gilead Sciences Inc3.73%